The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...
The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...
Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...
Pharmaceutical Technology on MSN
JPM26: Solid Biosciences banks on its AAV capsid to catalyse gene therapy success
The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...
News-Medical.Net on MSN
ELRIG announces Drs Stephen Ward and Annarita Miccio as keynote speakers for cell and gene therapy 2026
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the ...
A gene called SDR42E1 has been identified as a key player in how our bodies absorb and process vitamin D. Researchers found that disabling this gene in colorectal cancer cells not only crippled their ...
Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...
Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting its extraordinary biodiversity.
Pharmaceutical Technology on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Hosted on MSN
Gene-edited pigs may soon enter the Canadian market, but questions about their impact remain
The Canadian government is currently considering approving the entry of gene-edited pigs into the food system. Subscribe to our newsletter for the latest sci-tech news updates. Using CRISPR ...
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback